by U.S. Dept. of Health and Human Services, Agency for Health Care Policy and Research], Reproduced by U.S. Dept. of Commerce, National Technical Information Service in [Rockville, Md.?, Springfield, Va .
Written in English
|Other titles||Acute myocardial infarction|
|Statement||principal investigator: Barbara J. McNeil|
|Contributions||Acute Myocardial Infarction Patient Outcomes Research Team, United States. Agency for Health Care Policy and Research|
|The Physical Object|
|Pagination||1 v. (various pagings)|
A wide variation exists in the practice patterns of acute myocardial infarction (AMI) care worldwide, leading to differences in clinical outcomes. This study aims to evaluate the quality of process care and its impact on in-hospital outcomes among AMI patients in Pakistan, as no such study has been conducted in Pakistan thus far based upon recommended :// Request PDF | The treatment of acute myocardial infarction among new immigrants in Israel | We hypothesized that recent immigrants presenting with a poor cardiac profile may have a worse outcome Cardiovascular disease is the leading cause of death worldwide. The role of cardiac markers in the diagnosis, risk stratification, and treatment of patients with chest pain is vital. Patients with elevated cardiac troponin levels but negative CK-MB who were formerly diagnosed with unstable angina or minor myocardial injury are now reclassified as non–ST-segment elevation MI (NSTEMI) even in Cardiovascular disease is expected to be the main cause of death globally due to the rapidly increasing prevalence of obesity, hypertension and diabetes mellitus. Atherosclerotic lesions and plaque rupture are the most common cause of myocardial infarction. Resting lead ECG is the first diagnostic test for patients with chest pain and should be performed and interpreted within the first 10
2 days ago Myocardial infarction (MI) is a major cause of mortality and morbidity in the western world. As MI is a life threatening event it is hardly surprising that it often causes distress and impairment of quality of life for patients and their relatives, especially partners. For a substantial minority of families such consequences are profound. Most patients are clinically anxious on admission to Background The objectives of this population-based study were to describe trends of more than a decade () in duration of hospitalization after acute myocardial infarction (AMI), patient characteristics associated with varying lengths of stay, and the impact of declining length of stay on postdischarge mortality.. Methods The study sample consisted of patients discharged after AMI consequences. The adverse consequences of undertreated pain are considerable. Poorly man-aged acute pain may cause serious medical com-plications (e.g., pneumonia, deep venous throm-bosis), impair recovery from injury or proce-dures, and/or progress to chronic pain Undertreated chronic pain can impair an indi- BACKGROUND AND OBJECTIVES: Despite widespread use of the rotavirus vaccine in the last decade, dehydrating illnesses impact almost 2 billion children worldwide annually. Evidence supports oral rehydration therapy as a first-line treatment of mild to moderate dehydration. Ondansetron has proven to be a safe and effective adjunct in children with vomiting. We implemented a clinical pathway in
The British Cardiac Society commissioned this report to help address inconsistencies in the terminology for acute coronary syndromes and wide variations in the threshold for the diagnosis of myocardial infarction (MI) depending on the assay performed, the precision, and the sensitivity. In addition, several publications have highlighted potential problems with the application of the European The term re-infarction is used clinically for an acute MI that occurs within 28 days of an incident or recurrent MI. 11 The ECG diagnosis of suspected re-infarction following the initial MI may be confounded by the initial evolutionary ECG changes. Re-infarction should be considered when ST-elevation ≥ 1 mm recurs or new pathognomonic Q waves Abstract. For over a decade now, the Thrombolysis in Myocardial Infarction (TIMI) flow grade classification scheme has been successfully used to assess coronary blood flow in acute coronary syndromes (1).Although this scheme has been a valuable tool for comparing the efficacy of reperfusion strategies and identifying patients at higher risk of adverse outcomes in acute coronary syndromes, it The consequences of these discrepancies are significant—with higher mortality, major cardiovascular events and bleeding after MI in women compared to men. We review the sex disparities in pathophysiology, risk factors, presentation, diagnosis, treatment, and outcomes for acute MI, to answer the question: are they due to biology or bias, or both?